- /
- Supported exchanges
- / US
- / SLRC.NASDAQ
SLR Investment Corp (SLRC NASDAQ) stock market data APIs
SLR Investment Corp Financial Data Overview
SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, healt
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with SLR Investment Corp (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get SLR Investment Corp data using free add-ons & libraries
Get SLR Investment Corp Fundamental Data
SLR Investment Corp Fundamental data includes:
- Net Revenue: 210 M
- EBITDA:
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-04
- EPS/Forecast: 0.34
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SLR Investment Corp News
New
SLR Investment outlines initiatives to lift NII over next year as nonaccruals rise to 2
Earnings Call Insights: SLR Investment Corp. (SLRC) Q2 2026 MANAGEMENT VIEW * Michael Gross (Chairman, President & Co-CEO) framed “a more challenging environment for direct lending” and said t...
SLR Investment Corp. Q2 2026 Earnings Call Summary
SLR Investment Corp. Q2 2026 Earnings Call Summary - Moby Strategic Shift and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you inves...
Quant snapshot: Sandisk and Advanced Micro Devices lead top-rated names as Inter & Co and Shift4 Payments Dynamics lag
Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and health care, while weakness is more pronounced in financials and real estate. A ...
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
Key Points Arcutis Biotherapeutics is rapidly scaling its Zoryve dermatology line with revenue doubling in its most recent fiscal year. Vertex Pharmaceuticals maintains a dominant position in cystic ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.